Deprescribing antidepressants for depression – what is the evidence for and against?

Authors

Looi, Jeffrey C.L.
Allison, Stephen
Bastiampillai, Tarun
Kisely, Steve
Maguire, Paul A.
Woon, Luke S.C.
Anderson, Katrina
Malhi, Gin S.

Journal Title

Journal ISSN

Volume Title

Publisher

Access Statement

Research Projects

Organizational Units

Journal Issue

Abstract

Objective: Recent guidelines suggest that the overall quantity and duration of antidepressant prescriptions should be reduced. In this paper, we comment on the evidence both for and against this view. Methods: We critically review the arguments proposed by proponents of antidepressant deprescribing in the context of the evidence-base for the treatment of depression. Results: Proponents of deprescribing do not address the substantive issues of whether inappropriate prescribing has been demonstrated, and when prescribing is needed. Their arguments for deprescribing are rebutted in this context. Conclusions: Whether or not to deprescribe antidepressant medication needs to take into consideration the risk-benefit profile of the decision, the responsibility for which needs to be shared and based on the context of the patient’s depression, their preferences, experiences and perspectives.

Description

Citation

Source

Australasian Psychiatry

Book Title

Entity type

Publication

Access Statement

License Rights

Restricted until